US Patent 6914054 Methods and compositions for treating hepatitis C virus
Patent 6914054 was granted and assigned to Idenix Pharmaceuticals on July, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Oct, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+271 characters)
Article
Patent abstract
A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jean-Pierre Sommadossi0
Paulo LaColla0
Date of Patent
July 5, 2005
0Patent Application Number
098640780
Date Filed
May 23, 2001
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6914054 Methods and compositions for treating hepatitis C virus
Find more entities like US Patent 6914054 Methods and compositions for treating hepatitis C virus
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.